Richard Schilsky to Cost-Benefit Analysis
This is a "connection" page, showing publications Richard Schilsky has written about Cost-Benefit Analysis.
Connection Strength
0.262
-
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received. J Clin Oncol. 2016 08 20; 34(24):2925-34.
Score: 0.116
-
ASCO's initiative to define value in cancer care. Am J Manag Care. 2014 Aug; 20(11 Spec No.):E1.
Score: 0.102
-
Oral fluoropyrimidine treatment of colorectal cancer. Clin Colorectal Cancer. 2001 Aug; 1(2):95-103.
Score: 0.042
-
Gallium-67 scanning: limited usefulness in staging patients with non-Hodgkin's lymphoma. Am J Med. 1980 May; 68(5):695-700.
Score: 0.002